-+ 0.00%
-+ 0.00%
-+ 0.00%

Suzhou Ribo Files EU Application for Phase I Trial of SR122 Lipid Therapy

PUBT·11/09/2026 23:42:39
Listen to the news
Suzhou Ribo Files EU Application for Phase I Trial of SR122 Lipid Therapy
  • Suzhou Ribo Life Science submitted an EU Phase I clinical trial application for SR122 to treat mixed dyslipidemia and severe hypertriglyceridemia.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Suzhou Ribo Life Science Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261110-12406341), on November 09, 2026, and is solely responsible for the information contained therein.